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ABSTRACT 
Objective: To find out whether an isolated compound (IC) from the ethanolic extract of roots of ashwagandha prevents stress-induced 
hyperglycemia by direct interference with the action of increased concentration of corticosterone on hepatocytes or by preventing hyper-secretion 
of corticosterone or both. 
Methods: A group of rats served as controls, and those in another group were subjected to restraint (1 h) and forced swimming exercise (15 min), 
after a gap of 4 h daily for 4 w. The third group of rats received orally IC (5 mg/kg bw/rat) 1 h prior to exposure to stressors. After the last 
treatment period, a blood sample was collected and serum was separated for the estimation of corticosterone and glucose. In in vitro experiment, 
hepatocytes were treated with different concentrations of corticosterone (100, 200, 300, 400 and 500 ng/ml). In another set of experiment, 
hepatocytes were treated with different doses of IC (1, 10, 100, 1000 and 10 000 μg/ml of medium) along with corticosterone (400ng/ml). The 
concentration of glucose and activities of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) were determined after 
the treatment.  
Results: Stress exposure caused a significant increase in serum concentration of corticosterone and glucose whereas, administration of IC did not 
result in similar changes. Further, treatment of corticosterone in in vitro significantly increased the activities of PEPCK and G6Pase and 
concentration of glucose in a dose-dependent manner in hepatocytes. However, treatment with IC did not interfere with the corticosterone-induced 
an increase in the activities of PEPCK and G6Pase as well as the concentration of glucose in hepatocytes. 
Conclusion: The in vivo and in vitro results put together reveal that IC does not directly interfere with the action of corticosterone on hepatocytes. 
However, it prevents stress-induced hyperglycemia by suppressing hyper-secretion of corticosterone.  
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Stress disturbs the homeostatic equilibrium of the body and makes 
individuals susceptible to diseases. Stress affects physiological 
energy balance via the activation of hypothalamo-pituitary-
adrenocortical (HPA) and sympathetic-adreno-medullary (SAM) 
axes by producing an excess amount of glucocorticoids (GC) and 
catecholamines respectively [1]. The Liver is a central organ of 
energy metabolism and regulates carbohydrate metabolism in all 
vertebrates. A variety of environmental factors viz., fasting, hypoxia, 
temperature, stress and seasonality alter the liver metabolism [2]. 
The hepatocytes are the sites of endogenous glucose synthesis 
(gluconeogenesis) from non-carbohydrate sources. The 
neuroendocrine response to stress is characterized by excessive 
gluconeogenesis, glycogenolysis and insulin resistance. Chronic 
stress results in hyperglycemia affecting all the pathways of 
carbohydrate metabolism viz. glycolysis, tricaboxylic acid cycle, 
gluconeogenesis, hexose monophosphate shunt, glycogenolysis and 
glycogenesis [3-5]. Numerous studies reveal stress-induced 
alterations in the enzyme activities and concentrations of substrates 
of different pathways of carbohydrate metabolism [4, 6-8]. Stress 
increases gluconeogenesis by increasing the activities of key 
gluconeogenic enzymes viz. phosphoenolpyruvate carboxykinase 
(PEPCK), fructose-1, 6-bisphosphatase and glucose-6-phosphatase 
(G6Pase) and serves as a mechanism by which the availability of 
glucose is maintained. An increase in activities of hepatic G6Pase 
and PEPCK under different stressful conditions has been reported 
[9-12]. Hyperglycemia due to increased gluconeogenesis has a 
negative impact on the body as it results in insulin resistance [13].  
Glucocorticoids have long been known to regulate glucose 
homeostasis and have a vital role in gluconeogenesis. Metabolic 
effects of GC include an increase in blood glucose concentration 
through the activation of key enzymes involved in hepatic 
gluconeogenesis and inhibition of glucose uptake in peripheral 
tissues such as skeletal muscles [14]. Studies have shown that the 
primary effect of GC is exerted on existing enzymes to increase their 
activities. Numerous in vivo studies have shown the effects of a 
higher level of corticosterone on the activities of hepatic 
gluconeogenic enzymes in animal models under stressful condition 
[4, 10, 12, 15]. However, there are no reports on the effect of 
physiological concentration as well as stress level concentration of 
corticosterone on the activities of gluconeogenic enzymes of 
hepatocytes in in vitro. 
It is reported that stress-induced higher levels of GC affect different 
pathways of carbohydrate metabolism which might lead to 
metabolic syndrome like diabetes [16]. Since stress cannot be 
avoidable in the modern day society, the effects of stress can be 
controlled or prevented with suitable remedies. Though, numerous 
anti-stress synthetic compounds are available to prevent stress 
effects, because of their undesirable side effects there is a need for 
better compounds that can prevent stress effects and maintain 
normoglycemia despite experiencing stressful conditions. The herb 
ashwagandha (Withania somnifera), also knew as Indian Ginseng or 
Winter cherry has been well documented in the Ayruveda the 
traditional Indian medicine system and has multiple biological 
properties viz. antioxidant, adaptogenic, aphrodisiac, astringent and 
antiulcer [17-20]. Root extracts of ashwagandha are known to 
prevent stress-induced hyperglycemia, alterations in hepatic 
enzyme activities and glucose intolerance in in vivo [21-23]. It is also 
known that a root extract of ashwagandha prevents a rise in stress-
induced glucocorticoid levels [22, 23] in in vivo. However, whether 
the normoglycemia maintained by ashwagandha under stress 
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exposure is due to the prevention of excess secretion of GC alone or 
due to direct interference with gluconeogenic enzymes in 
hepatocytes or both is not known. Hence, in the present study effects 
of an isolated compound (IC) from root extract of ashwagandha on 
corticosterone-induced alterations in activities of gluconeogenic 
enzymes in hepatocytes in vitro were studied to understand whether 
or not IC acts directly on hepatocytes.  
MATERIALS AND METHODS 
Chemicals 
Corticosterone, Krebs-Ringer-Hepes (KRH), glucose 6 phosphate, 
dithiothreitol, adenosine diphosphate (ADP), 3-phosphoglycerate, 
phosphoenolpyruvate, 3-phosphoglycerate phosphokinase, and 
glyceraldehyde 3-phosphate dehydrogenase were purchased from 
Sigma Aldrich (United Kingdom). Tris-hydrochloric acid (HCL), 
trichloroacetic acid, sodium bicarbonate (NaHCO3), magnesium 
chloride (MgCl2) and BIS-TRIS buffer were obtained from Merks 
specialties, Pvt. Ltd (Mumbai, India). Serum glucose was measured by 
using the kit supplied by Span Diagnostics Ltd. (Gujarat, India). The 
ELISA kit for the estimation of serum concentration of corticosterone 
was supplied by Demeditec Diagnostics GmbH, Germany). All the other 
reagents and chemicals used were of analytical grade. 
Animals 
Adult male albino Wistar rats weighing 200-220 g were obtained from 
the inbred colony of the central animal facility of University of Mysore. 
The rats were provided a standard rat chow and water ad libitum and 
were kept in temperature 27±2˚C, under 12 h: 12 h light: dark cycle 
(light on 07:00-19:00 h). The experimental design was approved by 
Institutional Animal Ethics Committee of University of Mysore, India 
(Reference number UOM/IAEC/ 07/2016) and guidelines of the 
committee was followed for care and treatment of the rats.  
Isolation of active compound from ethanolic extract (EE) of 
ashwagandha root 
Earlier in vivo and in vitro studies showed the potential anti-stress 
activity of EE in roots of ashwagandha [22]. Hence, active compound 
was isolated from the EE as per the procedure of Nirupama et al. 
[23]. The EE was subjected to thin layer chromatography and was 
further fractionated in column chromatography. The extract was 
first run on thin layer chromatography plate to detect the number of 
compounds. The solvent system used contained chloroform and 
methanol. The same solvent was used for column chromatography 
to isolate a single compound. The compound isolated was subjected 
to nuclear magnetic resonance, infrared spectroscopy and liquid 
chromatography-mass spectrometry studies for the characterization 
of its chemical nature. 
In vivo experiment 
Adult male rats were divided into three groups of 5 animals each 
(n=5). First group rats were treated as controls and were maintained 
in a normal condition without any disturbance. Animals in the second 
group were exposed to two stressors viz., restraint (1 h) followed by a 
gap of 4 h to force swimming exercise (15 min) for 4 w. Each rat in the 
third group was orally treated with IC (5 mg/kg bw/rat) 1 h prior to 
exposure to stressors similar to rats in the second group. The fasting 
blood glucose concentration was measured in animals of all groups at 
weekly intervals. After the treatment period, the serum concentration 
of corticosterone was estimated by ELISA using kit and methods of the 
manufacturer (Demeditec Diagnostics GmbH, Germany). 
In vitro experiment 
Two sets of in vitro experiments were conducted using the 
hepatocytes. In the first experiment dose-dependent effect of 
corticosterone, if any on the activity of hepatic G6Pase and PEPCK 
were studied. The effect of IC on the action of corticosterone on the 
activities of gluconeogenic enzymes in hepatocytes was studied in 
the second experiment. Three replicates were used for each dose. 
Preparation of the liver tissue slice system 
The liver for these studies was collected from control rats used for in 
vivo experiment. The liver lobes were processed following the 
procedure of Wormser et al. [24]. Briefly, the liver lobes were placed 
on a glass surface and sliced into small pieces of about 0.5 x 0.5 x 0.5 
mm. Slices were incubated with KRH medium for 1 h and washed 
every 10 min with this medium. The slices were then divided into 
small portions (100-120 mg wet weight each) and were incubated in 
glass tubes containing 2 ml KRH medium at 37 ˚C for l h before 
experimentation. 
Effect of corticosterone on the activities of key enzymes of 
gluconeogenesis  
The liver slices were incubated with different concentrations of 
corticosterone (100, 200, 300, 400 and 500 ng/ml of medium) at 37 
˚C for 2.5 h. At the end of incubation, the tissue homogenate was 
used for the estimation of the activities of key gluconeogenic 
enzymes, G6Pase and PEPCK and concentration of glucose. 
Effect of IC on corticosterone-induced alterations in the 
activities of key enzymes of gluconeogenesis 
The liver slices were incubated with the different concentrations of 
IC (1, 10, 100, 1000 and 10 000 μg/ml of medium) and 400 ng 
corticosterone at 37 ˚C for 2.5 h. At the end of incubation, the tissue 
homogenate was used for the estimation of activities of G6Pase and 
PEPCK and concentration of glucose. 
Activity of G6Pase 
The activity of G6Pase was estimated following the method of 
Zhu et al. [25]. Liver slices were homogenized in 0.25 M sucrose 
solution and centrifuged at 3000 rpm for 15 min. The 
supernatant containing enzyme source (1 µl) was mixed with 
100 mmol BIS-TRIS buffer and 200 mmol of glucose 6 phosphate 
(substrate). The reaction mixture was incubated at 37 ˚C for 5 
min. The reaction was stopped by adding 20 % trichloroacetic 
acid, incubated for 5 min at 25 ˚C and centrifuged at 4000 rpm 
for 10 min to remove the precipitate. The supernatant (1 µl) was 
mixed with Taussky shorr color reagent for the development of 
color. The mixture was incubated at 25 ˚C for 5 min and the 
optical density was measured at 660 nm. The specific activity 
was expressed as μmol/mg/min. 
Activity of PEPCK 
The activity of PEPCK was estimated following the method of Kin et 
al. [26]. The enzyme sample was prepared in 5 ml of 100 mmol tris-
HCL at 4 ˚C. The sample (200 µl) was added to the reaction medium 
containing 500 mmol tris-HCl (pH 6.6), 350 mmol NaHCO3, 160 
mmol MgCl2, 6 mmol NADH, 20 mmol dithiothreitols, 0.2 M ADP, 36 
mmol 3-phosphoglycerate, 50 mmol phosphoenolpyruvate, 3-
phosphoglycerate phosphokinase and glyceraldehyde 3-phosphate 
dehydrogenase. The absorbance was read at 340 nm for 60 seconds 
at room temperature using a UV-Visible spectrophotometer. 
Concentration of glucose 
The concentration of glucose was estimated by glucose oxidase and 
peroxidase method using a kit manufactured by Arkray Healthcare, 
India and the procedure of the manufacturer was adopted. The 
sample (10 µl) was added to 1 ml reagent and incubated at 37 ˚C for 
10 min. Optical density was read at 505 nm and the concentration of 
glucose was expressed as mg/dl. 
Statistical analysis 
Mean±SE of each parameter was computed considering the data on 
at least 5 rats per group (N=5) and 3 replicates for each dose of in 
vivo and in vitro experiments respectively. The mean values of each 
parameter of different groups were compared using one way ANOVA 
followed by Duncan's multiple range test and judged significant if 
P<0.05.  
RESULTS 
In vivo experiment 
A significant increase in the serum concentration of corticosterone 
was observed in stressed rats compared to controls, whereas that 
of IC pretreated rats exposed to stressors was similar to controls 
(fig. 1). 
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Fig. 1: All values are mean±SE. Vertical bars to show serum concentration of corticosterone in control, stress and IC pretreated rats 
exposed to stress. Note the higher level of corticosterone in stressed rats compared with controls and IC pretreated rats exposed to stress. 
Bars with the same superscript letters do not significantly differ among themselves whereas those with different superscript letters 
significantly differ. IC-isolated compound from ashwagandha (n=5) 
 
There was a significant increase in the fasting blood glucose 
concentration in stress group rats from 1st w through 4th w, 
compared to controls. The IC pretreated rats exposed to stress did 
not differ from controls (fig. 2). 
 
 
Fig. 2: All values are mean±SE. Fasting blood glucose concentrations in control, stress and IC pretreated rats exposed to stress. Note the 
higher level of glucose in stressed rats compared with controls and IC pretreated rats exposed to stress. Groups with the same superscript 
letters at each weekly interval do not significantly differ among themselves whereas those with different superscript letters significantly 
differ. IC-isolated compound from ashwagandha (n=5) 
 
In vitro experiment 
Activities of G6Pase and PEPCK and concentration of glucose in 
hepatocytes 
There was a significant dose-dependent increase in the activities of 
G6Pase and PEPCK following treatment with increasing doses of 
corticosterone (100, 200, 300, 400 and 500 ng/ml) compared to 
control and vehicle control. However, G6Pase activity after the 
treatment of 300 ng did not significantly differ either from that of 200 
ng or 400 ng and that of PEPCK after the treatment of 400 ng did not 
significantly differ either from that of 300 ng or 500 ng (table 1). 
The concentration of glucose in the hepatocytes showed a dose-
dependent significant increase following treatment with increasing 
doses of corticosterone (100, 200, 400 and 500 ng/ml) compared to 
control and vehicle controls.  
However, glucose concentration after treatment of 300 ng did not 
significantly differ either from that of 200 ng or 400 ng (table 1). 
 
Table 1: Effect of corticosterone on the activities of key enzymes of gluconeogenesis and concentration of glucose in hepatocytes in vitro 
Groups Glucose 6 phosphatase (μmol/mg/min) Phosphoenolpyruvate carboxykinase (U/mg protein) Glucose mg/dl 
Control 2.74±0.04a 2.29±0.08a 29.35±0.87a 
Control+0.1 % DMSO  2.72±0.08a 2.25±0.05a 29.43±0.62a 
100 ng corticosterone 3.30±0.09b 4.40±0.10b 33.32±0.73b 
200 ng corticosterone 3.76±0.21c 4.86±0.04c 38.17±0.76c 
300 ng corticosterone 4.07±0.15cd 5.50±0.06d 40.32±1.69cd 
400 ng corticosterone 4.43±0.12d 5.88±0.03de 42.13±1.47d 
500 ng corticosterone 5.47±0.20e 6.06±0.14e 46.16±1.74e 
ANOVA F Value 







Note: All values are mean±SE, Groups with the same superscript letters do not significantly differ among themselves, whereas groups with different 
superscript letters significantly (P<0.05) differ as judged by ANOVA followed by Duncan’s test. df: degree of freedom. DMSO-dimethyl sulfoxide 
(n=3). 
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The activities of hepatic G6Pase and PEPCK and concentration of 
glucose were significantly increased in hepatocytes following 
treatment with corticosterone alone as well as cortico-
sterone+different concentrations of IC (1, 10, 100, 1000 and 10 000 
μg/ml) compared to controls and vehicle controls (1 % carboxy 
methyl cellulose) (table 2). 
 
Table 2: Effect of a compound isolated from ashwagandha root on corticosterone-induced alterations in the activities of key enzymes of 
gluconeogenesis and concentration of glucose in hepatocytes in vitro 
Groups Glucose 6 phosphatase 
(μmol/mg/min) 




Control 2.80±0.08a 2.44±0.05a 29.83±0.71a 
Control+1 % CMC 2.73±0.08a 2.41±0.07a 29.91±0.52a 
400 ng corticosterone 4.12±0.09b 5.61±0.06b 41.66±0.65b 
400 ng corticosterone+1 μg IC 4.01±0.11b 5.53±0.09b 40.14±0.42b 
400 ng corticosterone+10 μg IC 4.09±0.23b 5.60±0.10b 39.49±0.90b 
400 ng corticosterone+100 μg IC 4.07±0.08b 5.47±0.05b 40.69±1.25b 
400 ng corticosterone+1000 μg IC 4.41±0.09b 5.46±0.06b 40.65±1.26b 
400 ng corticosterone+10 000 μg IC 4.20±0.13b 5.51±0.05 b 40.77±0.48b 








Note: All values are mean±SE, Groups with the same superscript letters do not significantly differ among themselves, whereas groups with different 
superscript letters significantly (P<0.05) differ as judged by ANOVA followed by Duncan’s test. df: degree of freedom. CMC-carboxy methylcellulose, 
IC-isolated compound from ashwagandha (n=3). 
 
DISCUSSION 
Metabolic stress responses are mediated by hormones of the adrenal 
gland [27] and GC have long been known to regulate glucose 
homeostasis [28]. In the present study, increased concentration of 
corticosterone in stressed rats accompanied with higher blood 
glucose level indicates that stress-induced excess production of GC 
affected glucose metabolism. Blood glucose level is an important 
indicator of stress responses in animal [29] and a higher level of 
glucose in stressed rats is due to enhanced hepatic gluconeogenesis 
[30]. This was further supported by the present in vitro study 
wherein treatment of different doses of corticosterone significantly 
increased the activities of gluconeogenic enzymes, G6Pase and 
PEPCK of hepatocytes in a dose-dependent manner. Although most 
steps in gluconeogenesis are the reverse of those found in glycolysis, 
PEPCK and G6Pase regulate the rate process of gluconeogenesis by 
converting oxaloacetate to phosphoenolpyruvate and glucose-6-
phosphate to glucose respectively [31]. The over-expression of these 
enzymes in hepatocytes results in a reduction of glycogen synthesis 
and an increase in the production of glucose [32]. Hence, studies 
related to carbohydrate metabolism mainly focus on changes in the 
activities of these hepatic enzymes. 
An increase in the activities of gluconeogenic enzymes due to higher 
level of endogenous GC under stressful condition has been observed 
in in vivo system [10, 12, 15]. GC increase the synthesis of PEPCK 
and G6Pase by increasing the expression of their transcription 
factors [33, 34]. In addition to transcriptional regulation, studies 
have shown that GC directly enhance the activities of gluconeogenic 
enzymes under stressful condition [35-37]. Stress-induced increased 
gluconeogenesis results in hyperglycemia. Present in vivo and in 
vitro studies support this view as there was a significant increase in 
serum glucose concentration in in vivo as well as in hepatocytes in in 
vitro system accompanied with increased activities of PEPCK and 
G6Pase of hepatocytes in vitro following corticosterone treatment. 
The physiological concentration of corticosterone varies from 50 
to100 ng/ml and during stressful condition it rises from 120 to 425 
ng/ml. In the present study, corticosterone at the dose in the range 
of stress-induced alterations (100-500 ng/ml) significantly 
increased the activities of key enzymes of gluconeogenesis and 
glucose concentration in a dose-dependent manner. Thus action 
resembled the action of endogenous GC on glucose metabolism 
during stress. The severe implication of GC induced chronic 
hyperglycemia is insulin resistance and glucose intolerance [38] 
which may lead to type 2 diabetes mellitus [29]. Since stress induced 
higher level of GC is the main cause of hyperglycemia, it is logical 
that, either suppression of hypersecretion of GC or interference with 
action of corticosterone on hepatocytes under stressful conditions 
could prevent hyperglycemia and insulin resistance and consequent 
pathological implications. 
Interestingly, pretreatment of IC in rats exposed to stressors 
maintained normoglycemia and normal blood corticosterone levels as 
blood glucose level and corticosterone level of IC pretreated rats 
exposed to stressors were similar to controls in contrast to a 
hyperglycemic condition in rats exposed to stressors alone. In 
contrast, in in vitro system, treatment of IC did not prevent 
corticosterone induced enhanced activity of G6Pase and PEPCK as well 
as the concentration of glucose in hepatocytes as there was no 
difference in the activities of these enzymes and glucose concentration 
in corticosterone alone and corticosterone+IC treated hepatocytes. 
The fact that IC maintained normal blood concentration of glucose and 
corticosterone in stressed rats in in vivo and it did not prevent 
corticosterone induced increase in activities of gluconeogenic enzymes 
and glucose concentration in hepatocytes in in vitro, indicates that 
normoglycemic effect of IC during stressful condition in vivo is by 
suppressing the HPA activation and subsequent excess production of 
GC, whereas it does not directly interfere with the action of 
corticosterone on hepatocytes. This view is further supported by a 
report of Nirupama et al. [23] wherein treatment of IC from EE of 
ashwagandha root normalized the adrenal activity as well as the 
activities of gluconeogenic enzymes under stressful condition. 
Ashwagandha is known to stimulate the central nervous system (CNS) 
[17, 39] by modulating different neurotransmitter receptors 
particularly gamma-aminobutyric acid (GABA) [40]. The GABAergic 
neurons inhibit HPA activity by reducing the secretion of 
adrenocorticotropic hormone [41, 42]. However, under stressful 
condition there is depletion of GABA receptor binding in the CNS [43, 
44] which leads to the activation of the HPA axis. Studies have shown 
that extracts and active compounds of ashwagandha have GABA-like 
activity and also increase the production of GABA in brain [45-47]. 
Therefore, it is suggested that IC might induce higher levels of GABA or 
exert GABA like action in brain under the stressful condition and 
thereby suppress the activation of the HPA axis and the subsequent 
increase in serum level of corticosterone which is to be substantiated 
by future studies. 
CONCLUSION  
The in vivo and in vitro studies put together reveal that IC does not 
interfere with the action of corticosterone on hepatocytes, whereas, 
it prevents stress-induced hyperglycemia by preventing hyper-
secretion of corticosterone.  
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